FDA recall record

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%) recall — FDA D-1179-2023

Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.

Class IIIclassification
D-1179-2023official record ID
Oct 4, 2023report date

Recall record at a glance

Official recordD-1179-2023
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmRB Health (US) LLC
Report dateOct 4, 2023
Recall initiation dateAug 29, 2023
Quantity6,072 cases/36,426 individual selling units
LocationParsippany, NJ, United States

Official product description

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90

Why the product was recalled

Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.

Distribution information

USA nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.